NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Adverse Outcomes and Mortality in Liver Transplant
Adverse Outcomes and Mortality in Liver Transplant

NCT05477277

RecruitingNA

Sponsor: Mayo Clinic

Conditions: End Stage Liver DIsease, Sarcopenia, Sarcopenic Obesity, Cirrhosis

Interventions: MAsS

Countries: United States

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

1. All patients with end-stage liver disease undergoing evaluation for liver transplantation
2. Patient clinically indicated for MRI during transplant candidacy evaluation
3. Adult

Exclusion Criteria:

1\. Contra indication to MRI
Locations (1)
  • Phoenix, Arizona, United States